Dr. John K. Chan, MD

Dr. Chan practices at Mills-Peninsula Medical Center in Burlingame, California, part of Sutter Health.

Dr. Chan's NPI, 1962596551, was assigned on October 3, 2006. Dr. Chan graduated from David Geffen School of Medicine at UCLA in 1995. Dr. Chan holds California license A61661.

Dr. Chan's primary practice is Mills-Peninsula Medical Center, at 1501 Trousdale Drive, Burlingame, CA 94010 in San Mateo County. The practice phone is (650) 696-5400.

Dr. Chan's primary practice is Mills-Peninsula Medical Center in Burlingame, California, part of Sutter Health. Dr. Chan is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Chan to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chan practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Chan's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Chan is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Chan is licensed in California.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Chan treats.

CMS data shows 514 Medicare services from Dr. Chan across 5 procedure codes in 2024, for 202 Medicare patients. Medicare paid $70,160 for them.

CMS counts 202 Medicare patients who saw Dr. Chan in 2024. The largest group is 65 to 74, with 102 patients. 67% of them have high cholesterol, and 57% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chan's median patient age at 63, with 92% women.

In 2024, Dr. Chan wrote 108 Medicare Part D claims for 79 patients. 91% of them were for generic drugs. CMS names the drug for 71 of them, across 3 drugs with 11 or more claims each, at $692 in total drug cost. In 2023, CMS named 50 claims across 1 drug.

Dr. Chan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chan as offering telehealth. CMS counts 42 procedures of removal of the uterus by Dr. Chan, more than 98% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Chan, published from 2022 to 2023. 2022 was the busiest year, with 2. Dr. Chan has published most often in JAMA Netw Open. Dr. Chan's most frequent co-authors are John Kok-Sen Chan, MD, Daniel Stuart Kapp, MD and Yovanni Casablanca, MD.

Dmand AI links Dr. Chan to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Ovarian Neoplasms and Ovarian Diseases. Tesaro, Inc. sponsors the most, 3. Open Payments lists research payments to Dr. Chan that name 3 trials.

CMS Open Payments shows 1,891 general payments to Dr. Chan from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. AstraZeneca Pharmaceuticals LP paid the most, $799,049. It also lists 21 research payments totaling $2,831 from 2016 to 2017, naming 3 clinical trials.

Dr. Chan graduated from David Geffen School of Medicine at UCLA in 1995.

Dr. Chan is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.